Rosalind M Glasspool

Rosalind M Glasspool

UNVERIFIED PROFILE

Are you Rosalind M Glasspool?   Register this Author

Register author
Rosalind M Glasspool

Rosalind M Glasspool

Publications by authors named "Rosalind M Glasspool"

Are you Rosalind M Glasspool?   Register this Author

20Publications

948Reads

46Profile Views

Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.

Authors:
Yaohua Yang Lang Wu Xiang Shu Yingchang Lu Xiao-Ou Shu Qiuyin Cai Alicia Beeghly-Fadiel Bingshan Li Fei Ye Andrew Berchuck Hoda Anton-Culver Susana Banerjee Javier Benitez Line Bjørge James D Brenton Ralf Butzow Ian G Campbell Jenny Chang-Claude Kexin Chen Linda S Cook Daniel W Cramer Anna deFazio Joe Dennis Jennifer A Doherty Thilo Dörk Diana M Eccles Digna Velez Edwards Peter A Fasching Renée T Fortner Simon A Gayther Graham G Giles Rosalind M Glasspool Ellen L Goode Marc T Goodman Jacek Gronwald Holly R Harris Florian Heitz Michelle A Hildebrandt Estrid Høgdall Claus K Høgdall David G Huntsman Siddhartha P Kar Beth Y Karlan Linda E Kelemen Lambertus A Kiemeney Susanne K Kjaer Anita Koushik Diether Lambrechts Nhu D Le Douglas A Levine Leon F Massuger Keitaro Matsuo Taymaa May Iain A McNeish Usha Menon Francesmary Modugno Alvaro N Monteiro Patricia G Moorman Kirsten B Moysich Roberta B Ness Heli Nevanlinna Håkan Olsson N Charlotte Onland-Moret Sue K Park James Paul Celeste L Pearce Tanja Pejovic Catherine M Phelan Malcolm C Pike Susan J Ramus Elio Riboli Cristina Rodriguez-Antona Isabelle Romieu Dale P Sandler Joellen M Schildkraut Veronica W Setiawan Kang Shan Nadeem Siddiqui Weiva Sieh Meir J Stampfer Rebecca Sutphen Anthony J Swerdlow Lukasz M Szafron Soo Hwang Teo Shelley S Tworoger Jonathan P Tyrer Penelope M Webb Nicolas Wentzensen Emily White Walter C Willett Alicja Wolk Yin Ling Woo Anna H Wu Li Yan Drakoulis Yannoukakos Georgia Chenevix-Trench Thomas A Sellers Paul D P Pharoah Wei Zheng Jirong Long

Cancer Res 2019 02 17;79(3):505-517. Epub 2018 Dec 17.

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-18-2726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359948PMC
February 2019

No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.

Authors:
Lara E Sucheston-Campbell Rikki Cannioto Alyssa I Clay John Lewis Etter Kevin H Eng Song Liu Sebastiano Battaglia Qiang Hu J Brian Szender Albina Minlikeeva Janine M Joseph Paul Mayor Scott I Abrams Brahm H Segal Paul K Wallace Kah Teong Soh Emese Zsiros Hoda Anton-Culver Elisa V Bandera Matthias W Beckmann Andrew Berchuck Line Bjorge Amanda Bruegl Ian G Campbell Shawn Patrice Campbell Georgia Chenevix-Trench Daniel W Cramer Agnieszka Dansonka-Mieszkowska Fanny Dao Brenda Diergaarde Thilo Doerk Jennifer A Doherty Andreas du Bois Diana Eccles Svend Aage Engelholm Peter A Fasching Simon A Gayther Aleksandra Gentry-Maharaj Rosalind M Glasspool Marc T Goodman Jacek Gronwald Philipp Harter Alexander Hein Florian Heitz Peter Hillemmanns Claus Høgdall Estrid V S Høgdall Tomasz Huzarski Allan Jensen Sharon E Johnatty Audrey Jung Beth Y Karlan Reudiger Klapdor Tomasz Kluz Bożena Konopka Susanne Krüger Kjær Jolanta Kupryjanczyk Diether Lambrechts Jenny Lester Jan Lubiński Douglas A Levine Lene Lundvall Valerie McGuire Iain A McNeish Usha Menon Francesmary Modugno Roberta B Ness Sandra Orsulic James Paul Celeste Leigh Pearce Tanja Pejovic Paul Pharoah Susan J Ramus Joseph Rothstein Mary Anne Rossing Matthias Rübner Joellen M Schildkraut Barbara Schmalfeldt Ira Schwaab Nadeem Siddiqui Weiva Sieh Piotr Sobiczewski Honglin Song Kathryn L Terry Els Van Nieuwenhuysen Adriaan Vanderstichele Ignace Vergote Christine S Walsh Penelope M Webb Nicolas Wentzensen Alice S Whittemore Anna H Wu Argyrios Ziogas Kunle Odunsi Jenny Chang-Claude Ellen L Goode Kirsten B Moysich

Cancer Epidemiol Biomarkers Prev 2017 03 27;26(3):420-424. Epub 2016 Sep 27.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/lookup/doi/10.1158/1055-9965.EP
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-16-0631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500198PMC
March 2017

Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S26-9

*Beatson West of Scotland Cancer Centre, Glasgow, UK (SGCTG); †Medical Oncology Department, MD Anderson Cancer Centre, Madrid, Spain (GEICO); ‡Southern General Hospital, Glasgow, UK (SGCTG); §Gynecologic Oncology Unit, Fondazione IRCCS National Cancer institute of Milan (MITO), Milan, Italy; ‖Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden (NSGO); ¶Division of Gynecologic Oncology, NorthShore University Health System, University of Chicago Pritzker School of Medicine, Evanston, IL (GOG); #The Canberra Hospital, Canberra, Australia (ANZGOG); **University Hospital of Schleswig-Holstein Campus, Kiel, Germany (AGO); ††Department of Obstectrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea (KGOG); ‡‡Medical Oncology, Cochin-Hôtel Dieu, Paris Descartes University, Paris, France (GINECO); and §§UCL Cancer Institute, London, UK (NCRI/MRC).

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000209DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S20-5

*Jikei University School of Medicine, Tokyo, Japan; †Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ‡Osaka University Graduate School of Medicine, Osaka, Japan; §Kyoto University Graduate School of Medicine, Kyoto, Japan; ∥Keio University, Tokyo, Japan; ¶Tottori University School of Medicine, Tottori, Japan; #National Defense Medical College, Saitama, Japan; **Clinical Research, Innovation, and Education Center, Tohoku University Hospital, Sendai, Japan; ††Sunnybrook Hospital, Toronto, Canada; ‡‡UCL Cancer Institute, London, United Kingdom; §§Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; ∥∥Border Medical Oncology, Victoria, Australia; ¶¶Department of Pathology, Glasgow Royal Infirmary, Glasgow, United Kingdom; ##Institute of Cancer Sciences, University of Glasgow Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom; ***Gynecologic Oncology Center, Kiel, Germany; †††National Cancer Center, Goyang, Korea; ‡‡‡Institut Claudius Regaud, Toulouse, France; §§§National Cancer Institute, Naples, Italy; and ∥∥∥Princess Margaret Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000289DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S42-7

*Centre Léon Bérard, Lyon, France (GINECO); †MD Anderson Cancer Center, Houston, TX (GOG); ‡Kliniken-Essen-Mitte, Essen, Germany (AGO); §CHUM Hôpital Notre Dame, Montréal, Québec, Canada (NCIC-CTG); ∥FMHS, University of Auckland, Auckland, New Zealand (ANZGOG); ¶Tampere University Hospital, Tampere, Finland (NSGO); #UCL Cancer Institute, London, United Kingdom (NCRI MRC); **University Medecine, Göttingen, Germany (AGO); ††Institut de Cancérologie de l'Ouest René Gauducheau, Saint Herblain, France (GINECO); ‡‡Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom (SGCTG); §§Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy (MITO); and ∥∥University of Milan-Bicocca, Milan, Italy (MaNGO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000249DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S55-60

*ICO Centre René Gauducheau, Saint Herblain; †Hôpital de la Croix Rousse, Lyon, France; ‡UCL Cancer Institute, London, United Kingdom; §Memorial Sloan-Kettering Cancer Center, New York, NY; ∥Washington University School of Medicine, St Louis, MO; ¶Fundacion Instituto Valenciano de Oncologia, Valencia, Spain; #Sydney Local Health District, Sydney, Australia; **Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; ††Leiden University Medical Center, Leiden, the Netherlands; ‡‡Kliniken-Essen-Mitte, Essen, Germany; §§Seoul National University College of Medicine, Seoul, Republic of Korea; ∥∥Beatson Oncology Centre, Glasgow, United Kingdom; and ¶¶Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000228DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S78-82

From the *Australia and New Zealand Gynecological Oncology Group (ANZGOG); †Sunnybrook Hospital, Toronto, Canada, (GOG); ‡Beatson West of Scotland Cancer Centre, Glasgow, Scotland, (SGCTG); §University Hospital of Schleswig-Holstein Campus Kiel, Germany, (AGO); ∥Norwegian Radium Hospital, Oslo, Norway, (NSGO); ¶School of Medicine, Dongsan Hospital, Keimyung University, Korea, (KGOG); #Centre Leon Berard, Lyon, France, (GINECO); **Department of Radiation Oncology, Stritch School of Medicine, Loyola University, Chicago, IL, (RTOG); ††University Medical Center, Utrecht Cancer Center, Utrecht, the Netherlands, (DGOG); and the ‡‡Department of Obstetrics Gynaecology and Neonatology, The University of Sydney, Sydney, New South Wales, Australia, (ANZGOG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000239DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S83-9

*Department of Obstetrics & Gynecology, JR Sapporo Hospital, Sapporo, Japan; †Department of Obstetrics & Gynecology, School of Medicine, Keio University, Tokyo; ‡Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; §Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH; ∥Centre Hospitalier de L'Université de Montréal, Montreal, Quebec, Canada; ¶Oncology Department, Christchurch Hospital, Canterbury, New Zealand; #Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands; **Department Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM) (AGO), Essen, Germany; ††Norwegian Radium Hospital, Oslo, Norway; ‡‡Department of Obstetrics and Gynecology, Inje University Sanggye Paik Hospital, Seoul, South Korea; §§Department of Oncology and Hematology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; ∥∥Beatson West of Scotland Cancer Centre, Glasgow, Scotland; and ¶¶Department of Radiation Oncology, Stritch School of Medicine Loyola University, Chicago, IL.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000264DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S9-13

*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000257DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S90-5

*Saitama Medical University International Medical Center, Saitama, Japan (GOTIC); †Hyogo Cancer Center, Akashi, Japan (GOTIC); ‡Harvard Medical School, Boston, MA (RTOG); §Southern General Hospital, Glasgow, Lanarkshire, UK; ¶Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK (SGCTG); ∥Hospices Civils de Lyon, Lyon, France (GINECO); #Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada (GOG); **Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy (MITO); ††Kliniken Essen Mitte, Essen, Germany (AGO); ‡‡Seoul National University College of Medicine, Seoul, Korea (KGOG); §§Institut Claudius Regaud, Toulouse, France (GINECO); ¶¶Instituto Nazionale Tumori, Napoli, Italy (MITO); and ∥∥Prince of Wales Hospital, Sydney, Australia (ANZGOG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000297DOI Listing
November 2014

Concerning the feasibility of obtaining biopsies for research in relapsed ovarian cancer.

Int J Gynecol Cancer 2014 Jan;24(1):2-3

The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom Victoria Infirmary, Glasgow United Kingdom The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000060DOI Listing
January 2014

Clear cell carcinoma of ovary and uterus.

Curr Oncol Rep 2013 Dec;15(6):566-72

Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 0YN, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0346-0DOI Listing
December 2013

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Authors:
Jennifer Permuth-Wey Kate Lawrenson Howard C Shen Aneliya Velkova Jonathan P Tyrer Zhihua Chen Hui-Yi Lin Y Ann Chen Ya-Yu Tsai Xiaotao Qu Susan J Ramus Rod Karevan Janet Lee Nathan Lee Melissa C Larson Katja K Aben Hoda Anton-Culver Natalia Antonenkova Antonis C Antoniou Sebastian M Armasu François Bacot Laura Baglietto Elisa V Bandera Jill Barnholtz-Sloan Matthias W Beckmann Michael J Birrer Greg Bloom Natalia Bogdanova Louise A Brinton Angela Brooks-Wilson Robert Brown Ralf Butzow Qiuyin Cai Ian Campbell Jenny Chang-Claude Stephen Chanock Georgia Chenevix-Trench Jin Q Cheng Mine S Cicek Gerhard A Coetzee Linda S Cook Fergus J Couch Daniel W Cramer Julie M Cunningham Agnieszka Dansonka-Mieszkowska Evelyn Despierre Jennifer A Doherty Thilo Dörk Andreas du Bois Matthias Dürst Douglas F Easton Diana Eccles Robert Edwards Arif B Ekici Peter A Fasching David A Fenstermacher James M Flanagan Montserrat Garcia-Closas Aleksandra Gentry-Maharaj Graham G Giles Rosalind M Glasspool Jesus Gonzalez-Bosquet Marc T Goodman Martin Gore Bohdan Górski Jacek Gronwald Per Hall Mari K Halle Philipp Harter Florian Heitz Peter Hillemanns Maureen Hoatlin Claus K Høgdall Estrid Høgdall Satoyo Hosono Anna Jakubowska Allan Jensen Heather Jim Kimberly R Kalli Beth Y Karlan Stanley B Kaye Linda E Kelemen Lambertus A Kiemeney Fumitaka Kikkawa Gottfried E Konecny Camilla Krakstad Susanne Krüger Kjaer Jolanta Kupryjanczyk Diether Lambrechts Sandrina Lambrechts Johnathan M Lancaster Nhu D Le Arto Leminen Douglas A Levine Dong Liang Boon Kiong Lim Jie Lin Jolanta Lissowska Karen H Lu Jan Lubiński Galina Lurie Leon F A G Massuger Keitaro Matsuo Valerie McGuire John R McLaughlin Usha Menon Francesmary Modugno Kirsten B Moysich Toru Nakanishi Steven A Narod Lotte Nedergaard Roberta B Ness Heli Nevanlinna Stefan Nickels Houtan Noushmehr Kunle Odunsi Sara H Olson Irene Orlow James Paul Celeste L Pearce Tanja Pejovic Liisa M Pelttari Malcolm C Pike Elizabeth M Poole Paola Raska Stefan P Renner Harvey A Risch Lorna Rodriguez-Rodriguez Mary Anne Rossing Anja Rudolph Ingo B Runnebaum Iwona K Rzepecka Helga B Salvesen Ira Schwaab Gianluca Severi Viji Shridhar Xiao-Ou Shu Yurii B Shvetsov Weiva Sieh Honglin Song Melissa C Southey Beata Spiewankiewicz Daniel Stram Rebecca Sutphen Soo-Hwang Teo Kathryn L Terry Daniel C Tessier Pamela J Thompson Shelley S Tworoger Anne M van Altena Ignace Vergote Robert A Vierkant Daniel Vincent Allison F Vitonis Shan Wang-Gohrke Rachel Palmieri Weber Nicolas Wentzensen Alice S Whittemore Elisabeth Wik Lynne R Wilkens Boris Winterhoff Yin Ling Woo Anna H Wu Yong-Bing Xiang Hannah P Yang Wei Zheng Argyrios Ziogas Famida Zulkifli Catherine M Phelan Edwin Iversen Joellen M Schildkraut Andrew Berchuck Brooke L Fridley Ellen L Goode Paul D P Pharoah Alvaro N A Monteiro Thomas A Sellers Simon A Gayther

Nat Commun 2013 ;4:1627

Department of Cancer Epidemiology, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms2613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709460PMC
October 2013

Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.

Cancer Res 2005 Sep;65(17):7585-90

Centre for Oncology and Applied Pharmacology, University of Glasgow, Cancer Research UK Beatson Laboratories, Bearsden, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1715DOI Listing
September 2005

The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.

Neoplasia 2005 Jun;7(6):614-22

Cancer Research UK Centre for Oncology and Applied Pharmacology, University of Glasgow, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501281PMC
http://dx.doi.org/10.1593/neo.04766DOI Listing
June 2005

Telomerase-directed molecular therapeutics.

Expert Rev Mol Med 2002 Apr 22;4(10):1-25. Epub 2002 Apr 22.

Cancer Research UK Department of Medical Oncology, University of Glasgow, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1462399402004507DOI Listing
April 2002